Martin Shkreli, former Turing Pharmaceuticals CEO, who raised an HIV drug's price by 5,400%, was accused by his former lawyer of submitting false documents to US authorities and engaging in illegal stock trading. The lawyer is Shkreli’s co-defendant in the fraud case and is asking for a separate trial. However, Shkreli’s lawyer called the claim as “patently false".